Quick Answer
CNBX Pharmaceuticals Inc. reported Total Assets of $18.4 thousand for the year ending 2025.
- CNBX Pharmaceuticals Inc. showed a decrease of -41.3% in Total Assets from 2024 to 2025.
- This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 1, 2025.
- XBRL data for this metric is available from 2010 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $14.00 | Q4 2013: $31.4 thousand | Q1 2014: $1.1 thousand | Q2 2014: $0.00 | Q4 2014: $4.50 million | Q1 2015: $4.46 million | Q2 2015: $4.44 million | Q4 2015: $277.8 thousand | Q1 2016: $84.3 thousand | Q2 2016: $92.5 thousand | Q4 2016: $283.0 thousand | Q1 2017: $591.6 thousand | Q2 2017: $3.46 million | Q4 2017: $3.06 million | Q1 2018: $3.72 million | Q2 2018: $3.16 million | Q4 2018: $9.48 million | Q1 2019: $18.34 million | Q2 2019: $19.77 million | Q4 2019: $6.46 million | Q1 2020: $3.57 million | Q2 2020: $5.53 million | Q4 2020: $1.70 million | Q1 2021: $4.97 million | Q2 2021: $3.80 million | Q4 2021: $2.12 million | Q1 2022: $1.14 million | Q2 2022: $965.7 thousand | Q4 2022: $609.5 thousand | Q1 2023: $462.1 thousand | Q2 2023: $662.0 thousand | Q4 2023: $387.4 thousand | Q1 2024: $163.9 thousand | Q2 2024: $80.0 thousand | Q4 2024: $22.3 thousand | Q1 2025: $50.7 thousand | Q2 2025: $18.6 thousand | Q3 2025: $18.4 thousand | Q4 2025: $11.2 thousand.
- Over the full 14 years of available data (2010 to 2025), CNBX Pharmaceuticals Inc.'s Total Assets has declined by 80.6%.
- Historical annual values: Fiscal year 2025: $18.4 thousand | Fiscal year 2024: $31.4 thousand | Fiscal year 2023: $499.0 thousand | Fiscal year 2022: $811.2 thousand | Fiscal year 2021: $3.08 million | Fiscal year 2020: $2.22 million | Fiscal year 2019: $15.18 million | Fiscal year 2018: $3.18 million | Fiscal year 2017: $3.64 million | Fiscal year 2016: $23.7 thousand | Fiscal year 2015: $28.7 thousand | Fiscal year 2014: $114.2 thousand | Fiscal year 2013: $72.8 thousand | Fiscal year 2010: $95.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: